UCB Acquires Neurona Therapeutics in Landmark $1.15 Billion Deal, Bolstering Epilepsy Portfolio with Advanced Regenerative Cell Therapy
UCB, a global biopharmaceutical company renowned for its advancements in neurology and immunology, has formally announced a definitive agreement to...
July 4, 2025